NCT02068794 2025-11-18MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube CancerMayo ClinicPhase 1/2 Active not recruiting34 enrolled 12 charts
NCT03831932 2025-09-19Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting22 enrolled 12 charts
NCT00438880 2016-02-04Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaMayo ClinicPhase 1/2 Completed38 enrolled 8 charts